HCV NS5B polymerase inhibitor
This page covers all HCV NS5B polymerase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HCV NS5B RNA-dependent RNA polymerase.
Targets
HCV NS5B RNA-dependent RNA polymerase
Phase 3 pipeline (1)
- ME-609 · Medivir · Virology/Infectious Disease
ME-609 is a hepatitis C virus (HCV) NS5B polymerase inhibitor that blocks viral RNA replication.